Vivesto Stock

Vivesto Current Liabilities

The Current Liabilities of Vivesto (VIVE.ST) as of Aug 10, 2026 is 22.87 M SEK. In the previous year, Current Liabilities was 25.27 M SEK — a change of -9.49% (lower).

Current Liabilities

22.87 MSEK

YoY

-9.49%

Last updated:

Current Liabilities of Vivesto is 2026 22.87 M SEK. Current Liabilities of Vivesto was 2025 25.27 M SEK. It decreases by -9.49% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Current Liabilities of Vivesto is 22.87 M SEK in 2026.

Current Liabilities of Vivesto changed from 25.27 M SEK to 22.87 M SEK, representing a -9.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Vivesto since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Vivesto historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vivesto

All Key Metrics — Vivesto